Utilization of cadaveric kidneys from donors with reactive hepatitis C virus antibody or reactive hepatitis B core antibody.
Abrams
J
J
Delaware Valley Transplant Program, Philadelphia, PA 19130, USA.
Nathan
H M
HM
Brayman
K
K
Aradhye
S
S
D000328:Adult; D000368:Aged; D002102:Cadaver; D005260:Female; D006085:Graft Survival; D006510:Hepatitis B Antibodies / Q000097:blood*; D006512:Hepatitis B Core Antigens / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D018937:Hepatitis C Antibodies / Q000097:blood*; D006650:Histocompatibility Testing; D006801:Humans; D007668:Kidney; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D012189:Retrospective Studies; D015996:Survival Rate; D014019:Tissue Donors / Q000145:classification* / Q000600:supply & distribution
D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D018937:Hepatitis C Antibodies